Search results
Botanix’s hyperhidrosis treatment Sofdra gains FDA approval
Pharmaceutical Technology via Yahoo Finance· 1 day agoBotanix Pharmaceuticals has announced the receipt of approval from the US Food and Drug...
FDA approves Biotest’s plasma-derived treatment for immunodeficiencies
BioPharma-Reporter· 23 hours agoYimmugo, an intravenous immunoglobulin therapeutic, is the first therapy developed by Biotest to be...
FDA lifts hold on PTC Huntington’s disease trial
BioPharma Dive via Yahoo Finance· 23 hours agoPerhaps most importantly for the FDA, PTC reported no dose-limiting toxicities in the study. Adverse events were similar across treatment and placebo...
Dollar Tree gets FDA warning letter over recalled applesauce pouches
Consumer Affairs· 22 hours agoThe product was pulled from store shelves – but apparently, not all store shelves. The U.S. Food and Drug Administration (FDA) has sent a warning letter to Dollar Tree, telling ...
FDA Ban On Shock Devices For Those With Developmental Disabilities Faces New Hurdle
Disability Scoop· 1 day agoA bill making its way through the U.S. House of Representatives would limit the FDA’s ability to do...
McKesson (MCK) Introduces FDA-Approved Prostate Cancer Drug
Zacks via Yahoo Finance· 20 hours agoThe availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is...
MDMA DOA at FDA Advisory Committee
The National Law Review· 15 hours agoAvid readers know we have speculated that the legalization of psychedelics as a prescription medicine was “closer than ever.” Unfortunately, for...
WanaBana recall update: FDA sends warning letter to Dollar Tree over lead-contaminated cinnamon...
Yahoo Life· 3 days agoHealth officials in multiple states are still finding the recalled, lead-contaminated WanaBana...
FDA says Dollar Tree left lead-tainted applesauce pouches on store shelves for weeks after recall
WDBJ 7 Roanoke· 3 days agoThe FDA sent a warning letter to Dollar Tree this month and placed Negasmart, the Ecuadorian...
US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump
AOL· 14 hours agoThe agency gave traditional approval to patients four years and above who can walk, as well as accelerated approval for those who cannot. The FDA gave accelerated approval ...
